The Food and Drug Administration is advising consumers not to purchase or use Meta Forte, a product promoted and sold for sexual enhancement on various websites, and possibly in some retail stores.
Similar Posts
Intravascular PICC Catheter Recall: Bard Removes PowerPICC Intravascular Catheters
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramStokes Healthcare Inc. dba Epicur Pharma. Mount Laurel, NJ. 483 issued 05/23/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 05/23/2025
Short Title (70 char) Stokes Healthcare Inc. dba Epicur Pharma. Mount Laurel, NJ. 483 issued 05/23/2025
FEI Number 3002815949
Firm Name Stokes Healthcare Inc. dba Epicur Pharma
Record Type 483
State NFDA in Brief: FDA warns company for putting consumers at risk through distribution of non-compliant and misbranded drug ingredients
FDA issued a warning letter to Professional Compounding Centers of America Inc. (PCCA) for receiving and distributing adulterated and misbranded active pharmaceutical ingredients (APIs).FDA Roundup: May 31, 2024
The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAs
ANDA Submissions – Amendments and Requests for Final Approval to Tentatively Approved ANDAsHetero Labs Limited, Unit-IX – 09/26/2025
Hetero Labs Limited, Unit-IX – 09/26/2025. Country: India. Record Type: 483